Sanofi and Regeneron’s immunology blockbuster Dupixent was knocked down into second place as Eli Lilly’s diabetes medicine Trulicity took the top spot for January’s biggest TV ad spenders, according ...
AbbVie’s JAK inhibitor Rinvoq wasn’t even in the top 10 for pharma TV ad spending in February, but it shot up to first place in March as Eli Lilly’s Trulicity dropped down to fifth. Rinvoq is a follow ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback